Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022B10)
Article History
Received: 16 May 2024
Accepted: 22 July 2024
First Online: 5 August 2024
Declarations
:
: This study was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No.22/414–3616 and 22/415–3617). This study was registered at clinicaltrials.gov (NCT05749302 and NCT05761366).
: The patient whose data is published in this manuscript signed a written informed consent.
: The authors declare that they have no conficts of interest.